Clinical trial
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
NCT00003234 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003234 |
|---|---|
| Title | Vinorelbine in Treating Children With Recurrent or Refractory Cancers |
| Official title | A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refractory Malignancies |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma |
| Intervention type | Drug |
| Interventions | vinorelbine tartrate |
| Enrollment | 50 |
| Start date | May 1, 1998 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Oct 28, 2003 |
| Last update posted | Jul 28, 2014 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: